Exhibit 16.1

 

 

 

GRANT THORNTON LLP		July 10, 2023
801 Brickell Ave., Suite #2450
Miami, FL 33131
		U.S. Securities and Exchange Commission
D +1 305 341 8040		Office of the Chief Accountant
F +1 305 341 8099		100 F Street, NE
		Washington, DC 20549
		Re: TherapeuticsMD, Inc.
		File No. 001-00100
		Dear Sir or Madam:
		We have read Item 4.01 of Form 8-K of TherapeuticsMD, Inc. dated July 10, 2023, and agree with the statements concerning our Firm contained therein.
		Very truly yours,
		/S/ GRANT THORNTON LLP

 

 

 

U.S. member firm of Grant Thornton International Ltd